Zusammenfassung
Die Krebserkrankungen nehmen in der westlichen Welt insgesamt gering zu, auch wenn es einzelne Karzinome gibt, deren Inzidenz eine rückläufige Tendenz aufweist. So wird z.B. der Rückgang des Magen- oder des Zervixkarzinoms durch den weiteren Anstieg des Bronchuskarzinoms in einer Globalstatistik maskiert (Austoker 1994a, Travis 1995) (Tabelle 121).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Agrez MV, Coory M, Cockburn J (1998) Population screening for colorectal carcinom with fecal-occult blood testing. Cancer 81: 1803–1807
Austoker J (1994a) Cancerprevention: setting the scene. Br Med J 308: 1415–1420
Austoker J (1994b) Screening for ovarian, prostatic, and testicular cancers. Br Med J 309: 315–320
Beart RW, Curlee F (1978) Intestinal Stomas: managing the „unmentionable“. Geriatrics 33/11: 45–50
Berger HG, Gögler H, Kraas E, Schulz E, Bittner R (1979) Ergebnisse der chirurgischen Therapie des Dickdarmkarzinoms beim über 70jährigen Patienten. In: Rehn J (Hrsg) Der alte Mensch in der Chirurgie. Springer, Berlin Heidelberg New York, S 174–176
Berlin JD, Propert KJ, Trump D, Wilding G, Hudes G, Glick J, Burch P, Keller A, Loehrer P (1998) 5-Fluorouracil and leucovorin therapy in patients with hormone refractory prostate cancer: an Eastern Cooperative Oncology Group Phase II Study (E 1889). Am J Clin Oncol 21: 171–176
Bernabei R, Gambassi G, Lapane K, Landi F, Gatsonis C, Dunlop R, Lipsitz L, Mor V, for the SAGE Study Group (1998) Management of pain in elderly patients with cancer. J Am Med Assoc 279: 1877–1882
Blackledge G (1998) New developments in cancer treatment with the novel thymidylate synthase inhibitor raltitrexed („Tomudex“). Br J Cancer 77 [Suppl 2]: 29–37
Bonadonna G, Valagussa P (1981) Dose-response effect of adjuvant chemotherapy in breast cancer. N Engl J Med 304: 10–15
Burke W, Petersen G, Lynch P, Botkin J, Daly M, Garber J, Kahn MJE, McTiernan A, Offit K, Thomson E, Varricchio C, for the Cancer Genetics Studies Consortium (1997) Recommensations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. J Am Med Assoc 277: 915–919
Butler AN (1992) Screening mammography for older women: a case of mixed messages. Arch Intern Med 152: 922–925
Canellos GP, Hellman S (1982) The management of early breast cancer. N Engl J Med 306: 1430–1432
Catalona WJ, Smith DS, Ornstein DK (1997) Prostate cancer detection in men with serum PSA concentrations of 2,6 to 4,0 ng/ml and benign prostate examination. J Am Med Assoc 277: 1452–1455
Cleeland CS (1998) Undertreatment of cancer pain in elderly patients. J Am Med Assoc 279: 1914–1915
Colditz GA (1994) Oral contraceptive use and mortality during 12 years of follow-up: The Nurses Health Study. Ann Intern Med 120: 821–826
Council on Scientific Affairs (1984) Early detection of breast cancer. JAMA 252: 3008–3011
Crawford ED, Eisenberger MA, McLeod DG, Spaulding JT, Benson R, Dorr FA, Blumenstein BA, Davis MA, Goodman PJ (1989) A controlled trial of leuprolide with and without flutamide in prostatic carcinoma. N Engl J Med 321: 419–424
Curless R, French JM, Williams GV, James OF (1994) Colorectal carcinoma: do elderly patients present differently? Age Ageing 23: 102–107
de Graaf H, Willemse PHB, Sleijfer DT (1994) Review: breast cancer in elderly patients. Age Ageing 23: 424–427
Delendi M, Gardison D. Ribol E, Sasco AJ (1989) Latent colorectal cancer found at necropsy. Lancet ii: 1331–1332
Dodd GD (1992) American Cancer Society guidelines on screening for breast cancer: an overview. Cancer 69: 177–180
Dukes CE, Bussey HJR (1958) The spread of rectal cancer and its effect on prognosis. Br J Cancer 12: 1860–1864
Dunlop M, Campbell H (1997a) Screening for people with a family history of colorectal cancer. Br Med J 314: 1779–1780
Dunlop MG (1997b) Colorectal cancer. Br Med J 314: 1882–1885
Early Breast Cancer Trialists Collaborative Group (1998) Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet 351: 1451–1467
Fentiman IS, Tirelli U, Monfardini S, Schneider M, Festen J, Cognetti F, Aapro MS (1990) Cancer in the elderly: why so badly treated? Lancet 335: 1020–1022
Fielding LP, Phillips RKS, Hittinger R (1989) Factors influencing mortality after curative resection for large bowel cancer in elderly patients. Lancet i: 595–597
Finlay IG, Meek DR, Gray HW, Duncan JG, McArdle CS (1982) Incidence and detection of occult hepatic metastases on colorectal carcinoma. Br Med J 284: 803–805
Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE (1994) Risk of cancer in BRCA1-mutation carriers. Lancet 343: 692–695
Gibbons RP, Correa RJ, Bannen GE, Weissman RM (1989) Total prostatectomy for clinically localised prostatic cancer: long-term results. J Urol 141: 564–566
Gomez ER, Rosenthal D (1984) Management of a subcutaneous colostomy perforation. Dis Col Rect 27: 651–653
Greenwald P, Nasca PC, Lawrence CE, Horton J, McGarrah RP, Gabriele T, Carlton K (1978) Estimated effect of breast self-examination and routine pyhsician examinations on breast cancer mortality. N Engl J Med 299: 271–273
Howell A, Dowsett M (1997) Recent advances in endocrine therapy of breast cancer. Br Med J 315: 863–866
Hubay CA, Pearson OH, Marshall JS, Rhodes RS, DeBanne SM, Rosenblatt J, Mansour EG, Hermann RE, Jones JC, Flynn WJ, Eckert C, McGuire WL (1980) Adjuvant chemotherapy, antiestrogen therapy and immunotherapy for stage II breast cancer: 45-month follow-up of a prospective, randomized clinical trial. Cancer 46: 2805–2808
Hunter DJ, Spiegelman D, Adami HO, Beeson L, Van den Brandt P, Folsom AR, Fraser GE, Goldbohm RA, Graham S, Howe GR, Kushi LH, Marshall JR, McDermott A, Miller AB, Speizer FE, Wolk A, Yaun SS, Willett W (1996) Cohort studies of fat intake and the risk of breast cancer — pooled analysis. N Engl J Med 334: 356–361
Irvin TT (1988) Prognosis of colorectal cancer in the elderly. Br J Surg 75: 419–421
Jack CI, Lye M, Lesley F, Wilson G, Donnelly RJ, Hind CR (1997) Surgery for lung cancer: age alone is not a contraindication. Int J Clin Pract 51: 423–426
Jensen J, Kewenter J, Haglind E, Lycke G, Svensson C, Ahren C (1986) Diagnostic accuracy of double contrast enema and rectosigmoidoscopy in connection with faecal occult blood testing of rectosigmoid neoplasms. Br J Surg 73: 961–964
Johansson JE, Adami HO, Andersson SO, Bergström R, Krusemo UB, Kraaz W (1989) Natural history of localised prostatic cancer. Lancet i: 799–803
Kemppainen M, Räihha I, Rajala T, Sourander L (1993) Delay in diagnosis of colorectal cancer in elderly patients. Age Ageing 22: 260–264
Kerlikowske K, Grady D, Barclay J, Sickles EA, Eaton A, Ernster V (1993) Positive predictive value of screening mammography by age and family history of breast cancer. J Am Med Assoc 270: 2444–2450
Klein LA (1979) Prostatic carcinoma. N Engl J Med 300: 824–833
Klurfeld DM (1992) Dietary fiber-mediated mechanism in carcinogenesis. Cancer Res 52 [Suppl]: 2055S–2059S
Kobayashi T, Kawakubo T (1994) Prospective investigation of tumor markers and risk assessment in early cancer screening. Cancer 73: 1946–1953
Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O (1996) Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 348: 1467–1471
Lamas AM, Horwitz RI, Peck D (1984) Usefulness of mammography in the diagnosis and management of breast disease in postmenopausal women. JAMA 252: 2999–3002
Landrigan PJ (1998) Asbestons — still a carcinogen. N Engl J Med 338: 1618–1619
Lilienfeld AM (1963) The epidemiology of breast cancer. Cancer Res 23: 1503–1513
Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, Ederer F, for the Minnesota Colon Cancer Control Study (1993) Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 328: 1365–1371
Margreiter R (1980) Die Bedeutung der Hormonrezeptor-Analyse für die Therapie des Mammakarzinoms. Berichte Öst Ges Klin Chemie 3: 80–85
Miller AB, Bulbrook RD (1982) Screening, detection, and diagnosis of breast cancer. Lancet i: 1109–1111
Moon TD, Sloane BB (1989) Prostatic adenocarcinoma. J Am Geriatr Soc 37: 55–64
Moon TD (1992) Prostate cancer. J Am Geriatr Soc 40: 622–627
Mushlin AI (1985) Diagnostic tests in breast cancer. Ann Intern Med 103: 79–85
Nemunaitis J, Klemow S, Tong A, Courtney A, Johnston W, Mack M, Taylor W, Solano M, Stone M, Mallams J, Mues G (1998) Prognostic value of K-ras mutations, ras oncoprotein, and c-erb B2 oncoprotein expression in adenocarcinoma of the lung. Am J Clin Oncol 21: 155–160
Nobile MT, Barzacch MC, Sanguineti O, Gozza A, Vincenti M, Lavarello A, Cognein P, Lionetto R, Oercivale PL, Bertoglio S, Murolo C, Esposiot M, Vannozzi MO, Rosso R (1998) Activity of high dose 24 hour 5-fluorouracil infusion plus l-leucovorin in advanced colorectal cancer. Anticancer Res 18: 517–521
Oesterling JE (1991) Prostate-specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 145: 907–923
Oesterling JE, Jacobsen SJ, Chute CG, Guess HA, Girman CJ, Panser LA, Lieber MM (1993) Serum prostate-specific antigen in an community-based population of healthy men. J Am Med Assoc 270: 860–864
Papatestas AE, Mulvihill M, Josi C, Ioannivich J, Lesnick G, Aufses AH (1980) Parity and prognosis in breast cancer. Cancer 45: 191–194
Parshad R (1997) Adjuvant therapy in colorectal cancer. Trop Gastroenterol 18: 139–144
Patterson WB (1989) Surgical issues in geriatric oncology. Semin Oncol 16: 57–65
Patterson WB (1992) Cancer in old people: an overview. In: Evans JG, Williams TF (eds) Oxford textbook of geriatric medicine. Oxford University Press, Oxford New York Tokyo
Paulson DF, Moul JW, Walther PJ (1990) Radical prostatectomy for clinical stage T1-2N0M0 prostatic adenocarcinoma: long-term results. J Urol 144: 1180–1184
Pelger RC, Hamdy NA, Zwinderman AH, Lycklama A, Nijholt AA, Papapoulos SE (1998) Effects of the bisphosphonatc olpadronate in patients with carcinoma of the prostate metastatic to the skeleton. Bone 22: 403–408
Prager E (1984) The continent colostomy. Dis Col Rect 27: 235–237
Prandoni P, Lensing AWA, Büller HR, Cogo A, Prins MH, Cattelan AM, Cuppinie S, Noventa F, ten Cate JW (1992) Deept-vein thrombosis and the incidence of subsequent symptomatic cancer. N Engl J Med 327: 1128–1133
Rosell R, Gomez-Codina J, Camps C, Maestre J, Padille J, Canto A, Mate JL, Li S, Roig J, Olazabal A, Canela M. Ariza A, Skacel Z, Morera-Prat J, Abad A (1994) A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-smallcell lung cancer. N Engl J Med 330: 153–158
Scalliet P (1991) Radiotherapy in the elderly. Eur J Cancer 27: 3–5
Smith IE (1996) Prophylactic cranial irradiation for small-cell lung cancer. Lancet 348: 350
Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, Redwine E (1987) Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 317: 909–916
Steinberg KK, Thacker WD, Smith SJ, Stroup DF, Zack MM, Flanders WD, Berkelman RL (1991) A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer. J Am Med Assoc 265: 1985–1990
Stjernsward J (1998) WHO cancer pain relief program. Cancer Surv 7: 195–208
Stolley PD (1983) Lung cancer in women — five years later, situation worse. N Engl J Med 309: 428–429
Swedish Rectal Cancer Trial (1997) Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 336: 980–987
Travis WD, Travis LB, Devesa SS (1995) Lung cancer. Cancer Suppl 75: 191–202
Vähäkangas KH, Samet JM, Metcalf RA, Welch JA, Bennett WP, Lane DP (1992) Mutations of p53 and ras genes in radon-associated lung cancer from uranium miners. Lancet 339: 576–580
Van den Brandt PA, Goldbohm RA, Van Veer P (1995) Alcohol and breast cancer: results from the Netherlands Cohort Study. Am J Epidemiol 141: 907–915
Walsh SJ, Begg CB, Carbone CC (1989) Cancer chemotherapy in the elderly. Semin Oncol 16: 66–75
Warmuth MA, Sutton LM, Winer EP (1997) A review of hereditary breast cancer: from screening to risk factor modification. Am J Med 102: 107–115
Westeel V, Murray N, Gelmon K, Shah A, Sheehan F, McKenzie M, Wong F, Morris J, Grafton C, Tsang V, Goddard K, Murphy K. Parsons C, Amy R, Page R (1998) New combination of the old drugs for elderly patients with small-cell lung cancer: a phase II study of the PAVE regimen. J Clin Oncol 16: 1940–1947
Willers H, Wurschmidt F, Bunemann H, Heilmann HP (1998) High-dose radiation therapy alone for inoperable non-small cell lung cancer — experience with prolonged overall treatment times. Acta Oncol 37: 101–105
Willett WC, Stampfer MJ, Colditz GA, Rosner BA, Speizer FE (1990) Relation of meat and fiber intake to the risk of colon cancer in a prospec-tive study among women. N Engl J Med 323: 1664–1672
Zachariah B, Casey L, Balducci L (1995) Radiotherapy of the oldest old cancer patients: a study of effectiveness and toxicity. J Am Geriatr Soc 43: 793–795
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer-Verlag Wien
About this chapter
Cite this chapter
Tragl, K.H. (1999). Die Karzinomkrankheit. In: Handbuch der Internistischen Geriatrie. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6409-9_15
Download citation
DOI: https://doi.org/10.1007/978-3-7091-6409-9_15
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-7317-6
Online ISBN: 978-3-7091-6409-9
eBook Packages: Springer Book Archive